tirzepatide for psoriasis GLP-1 Agonists and Psoriasis: A Potential Novel Therapeutic Approach Bridging Dermatology and Metabolic Medicine:
Description
Both use once-weekly subcutaneous injections
Mounjaro starts at 2.5 mg weekly for four weeks, then increases to 5 mg
Notably, both agents produced significant reductions in depression and asthma prevalence, accompanied by decreased antidepressant and asthma medication usage ( Tables S14S17 ), suggesting clinically meaningful improvement in symptomatic disease burden
strength training helps maintain metabolic rate and functional capacity
Our expert team will help you select the right medication and provide a personalized plan to keep you on track
Non-stimulating Non-habit-forming
